Pluricell Biotech – Creating a Commercially-Available Supply of Pluripotent Stem Cells

Finding Genius Podcast

Richard Jacobs

Medicine, Health & Fitness

4.4 • 1K Ratings

🗓️ 13 March 2017

⏱️ 31 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

PluriCell is a biotechnology based company whose goal is to become a continuous, reliable, commercial source of induced pluripotent stem cells (iPS cells). With these type of cells, they can virtually generate any cell type of the human body, from heart cells to liver, skin & more, although their first project is to successfully and repeatably create the progenitors of a certain type of heart cell.
Marcos Valadares, CEO and Diogo Biagi, CSO, co-founders of Pluricell Biotech share how the company was formed and what is it's current focus. The application of this technology knows no bounds; cosmetic, food, therapeutic and agricultural chemicals are some of the examples. Though commercialization of their products face geographical limitations currently, but the company aims to overcome that and make its way to the international markets.
Pluricell is making a difference in people's lives through this amazing technology and it is only going to get better from here.
So make sure you listen, subscribe and review the podcast. Don’t forget to donate bitcoins to help us keep making more content for YOU.

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to Almost Here, Around the Corner of Future Technology Podcasts with Richard Jacobs.
0:07.0	Future Technologies is poised to transform our lives for better or worse for the focus of this podcast. Almost here
0:14.3	means these technologies are now here and starting to be used. We're just around the
0:18.8	corner. For Bitcoin to Artificial Intelligence, 3D printing, blockchain, virtual reality, and more.
0:27.0	Hi this is Richard Jacobs with Future Tech Podcast, almost here around the corner technology.
0:32.0	Today I have two gentlemen from Plurists, how about almost here around the corner technology.
0:32.8	Today I have two gentlemen from Plurist
0:34.8	Salob biotech, co-founders,
0:36.8	Marcos Valadares and Diogo Biage.
0:40.6	Marcos is a CEO and co-founder, Yogo is co-founder and CSO, chief scientific officer.
0:47.0	How are you guys doing?
0:49.0	We're doing great.
0:51.0	Thank you very much, Richard, for the opportunity.
0:53.0	Yeah, yeah, we're fine.
0:55.0	Well, would you guys start off and let listeners know what do you guys do at Bluricell Biotech?
1:01.0	Yeah, well, Blusas started 2013 and it's actually a spinoff of Diogo's PhD project
1:09.7	from Paolo and it started with his idea of developing a disease model for genetic disease he was studying which is
1:21.6	hypertrophy cardiomyopathy and after he could he got in touch with the technology
1:28.7	I.
1:29.2	I. Technology which stands for induced throughipotence themselves,
1:33.0	which was a very new technology at that moment already.
1:38.0	We really saw there's a potential opportunity for us to start a company and to develop the technology
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Richard Jacobs, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Richard Jacobs and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.